Jean Bousquet Selected Research

azelastine (Optivar)

10/2022	Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference.
9/2018	Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
3/2016	Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
1/2016	Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
4/2015	Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
7/2012	Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
5/2012	A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean Bousquet Research Topics

Disease

113	Asthma (Bronchial Asthma) 01/2022 - 01/2002
51	Allergic Rhinitis 10/2022 - 01/2004
47	Hypersensitivity (Allergy) 10/2022 - 03/2003
31	Rhinitis 12/2021 - 01/2004
20	COVID-19 10/2022 - 01/2020
11	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 03/2004
11	Inflammation (Inflammations) 11/2020 - 06/2002
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 05/2003
8	Infections 01/2022 - 01/2006
7	Rhinosinusitis 01/2022 - 09/2009
7	Nasal Polyps (Nasal Polyp) 01/2022 - 11/2010
7	Anaphylaxis (Anaphylactic Shock) 01/2022 - 06/2004
7	Food Hypersensitivity (Food Allergy) 01/2021 - 10/2013
5	Atopic Dermatitis (Atopic Eczema) 11/2020 - 11/2006
5	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2020 - 09/2009
4	Eczema 01/2021 - 02/2014
3	Cough 05/2022 - 12/2020
3	Chronic Cough 05/2022 - 10/2009
3	Drug Hypersensitivity (Drug Allergy) 01/2020 - 06/2004
3	Virus Diseases (Viral Diseases) 01/2020 - 01/2006
3	Urticaria (Hives) 01/2020 - 06/2004
3	Perennial Allergic Rhinitis 01/2020 - 03/2005
2	Sinusitis 01/2022 - 04/2011
2	Cytokine Release Syndrome 12/2020 - 11/2020
2	Chronic Disease (Chronic Diseases) 12/2020 - 04/2011
2	Neoplasms (Cancer) 11/2019 - 01/2019
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 05/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

44	AllergensIBA 01/2022 - 08/2002
32	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2002
28	Immunoglobulin E (IgE)IBA 01/2022 - 01/2004
16	Fluticasone (Cutivate)FDA LinkGeneric 10/2022 - 01/2002
11	Pharmaceutical PreparationsIBA 10/2022 - 03/2003
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
10	VaccinesIBA 10/2022 - 01/2004
9	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 10/2003
8	Omalizumab (Xolair)FDA Link 01/2022 - 04/2004
7	AntibodiesIBA 10/2022 - 11/2010
7	azelastine (Optivar)FDA LinkGeneric 10/2022 - 05/2012
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2003
5	BNT162 VaccineIBA 10/2022 - 01/2021
5	Monoclonal AntibodiesIBA 01/2022 - 12/2008
5	Air Pollutants (Pollutants, Air)IBA 12/2021 - 01/2020
5	Biological ProductsIBA 11/2020 - 06/2003
5	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 01/2002
5	SteroidsIBA 08/2012 - 06/2003
5	Interleukin-8 (Interleukin 8)IBA 12/2009 - 06/2002
5	GlucocorticoidsIBA 01/2005 - 01/2002
4	TabletsIBA 03/2022 - 01/2011
4	CytokinesIBA 12/2021 - 03/2002
4	anti-IgE antibodiesIBA 12/2019 - 04/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 02/2005
4	MP29-02IBA 01/2016 - 05/2012
4	NF-kappa B (NF-kB)IBA 12/2009 - 06/2003
4	montelukast (Singulair)FDA Link 06/2009 - 01/2002
3	Histamine Antagonists (Antihistamines)IBA 07/2022 - 02/2005
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2002
3	ORALIT (ORS)IBA 12/2021 - 09/2012
3	Oxygen (Dioxygen)IBA 01/2021 - 12/2020
3	Particulate MatterIBA 11/2020 - 12/2015
3	Environmental Pollutants (Pollutants, Environmental)IBA 03/2020 - 04/2017
3	Enterotoxins (Enterotoxin)IBA 01/2019 - 11/2010
3	ragweed pollenIBA 01/2019 - 01/2018
3	SmokeIBA 12/2018 - 11/2008
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 04/2017 - 12/2007
3	desloratadine (Aerius)FDA LinkGeneric 05/2013 - 01/2010
3	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2013 - 10/2009
3	Beclomethasone (Beclometasone)FDA Link 03/2012 - 01/2002
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 06/2009 - 01/2002
3	levocetirizine FDA LinkGeneric 10/2006 - 10/2004
2	Antitussive Agents (Antitussives)FDA Link 05/2022 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2014
2	AnkyrinsIBA 03/2022 - 01/2021
2	CurcuminIBA 03/2022 - 12/2020
2	AntioxidantsIBA 03/2022 - 01/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 07/2020
2	SootIBA 12/2021 - 12/2015
2	LipidsIBA 11/2021 - 01/2005
2	COVID-19 VaccinesIBA 10/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
2	Nitrogen DioxideIBA 11/2020 - 12/2015
2	Indicators and Reagents (Reagents)IBA 01/2020 - 12/2015
2	rupatadineIBA 01/2020 - 01/2019
2	SolutionsIBA 01/2019 - 06/2018
2	P-2 (P 2)IBA 01/2018 - 11/2008
2	Interleukin-5 (Interleukin 5)IBA 11/2010 - 11/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 03/2002
2	Formoterol Fumarate (Oxis)FDA Link 02/2008 - 12/2007
2	Budesonide (Pulmicort)FDA LinkGeneric 12/2007 - 01/2002
2	RibomunylIBA 01/2006 - 01/2006
2	Expectorants (Mucolytics)IBA 01/2006 - 02/2005
2	EicosanoidsIBA 01/2005 - 06/2002

Therapy/Procedure

25	Therapeutics 05/2022 - 03/2004
16	Immunotherapy 12/2019 - 12/2007
7	Drug Therapy (Chemotherapy) 10/2022 - 02/2005
4	Home Nursing (Nursing, Home) 01/2022 - 07/2020
3	Self Medication 04/2019 - 01/2019
2	Precision Medicine 01/2021 - 01/2017
2	Long-Term Care 12/2020 - 12/2020